Ketoprofen in the treatment of rheumatoid arthritis. Double-blind, cross-over placebo comparison.
In a two week double-blind cross-over trial of ketoprofen versus placebo in twelve patients, ketoprofen was shown to have substantial anti-inflammatory activity and to be more effective than placebo. Clinical and biological tolerance were excellent.
D000700:Analgesics / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001577:Benzophenones / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D007660:Ketoprofen / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos
D000700:Analgesics; D001577:Benzophenones; D010919:Placebos; D007660:Ketoprofen